Tag: GLP-1 receptor agonists

A GeroScience commentary argues that veterinary conditional approval frameworks and existing mortality-benefiting drugs could guide human lifespan therapeutics development.

A new narrative review argues that GLP-1 receptor agonists should be repositioned as foundational cardio-renal-metabolic protectors, with trial evidence extending ...

An exploratory mouse study found that 28 days of semaglutide exposure significantly increased the osteoblast-covered bone surface without detectable changes ...

A meta-analysis of five phase 3 trials found that incretin-based therapies lowered DXA-measured lean body mass versus comparators, though certainty ...

A new narrative review argues that chronic inflammation, gut microbiota dysbiosis, and mitochondrial dysfunction are reshaping type 2 diabetes care ...

A systematic review of nine randomized studies finds exploratory biomarker and neuroimaging signals for GLP-1 receptor agonists and SGLT-2 inhibitors ...

A study of 1,061 endocrinologists found that higher scores on ABIM's Longitudinal Knowledge Assessment were associated with a larger increase ...

Nausea, vomiting, diarrhea and constipation are the price many people pay for the remarkable weight loss and blood sugar control ...

Current evidence shows that while GLP-1 receptor agonists increase retained gastric contents, they have not been linked to a corresponding ...

A student-led study at an osteopathic medical college found that three paid AI platforms varied widely in reference quality and ...